Learning Objectives:

1. Appreciate findings associated with CRS in COVID-19.

2. Understand the potential role of tocilizumab in COVID-19.

3. Recognize the data utilized to build study schema of the COVIDOSE clinical trial.


Session date: 
Tuesday, May 12, 2020 - 8:30am to 9:30am
Speaker Name: 
Pankti Reid, M.D., MPH
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.